Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Error message

Could not retrieve the oEmbed resource.

Biology Behind Targeted Therapy for Lymphomas

Dr. Staudt talks about how ibrutinib is a very specific agent that has a high degree of efficacy with only modest side effects in treating the ABC form of Diffuse B-cell Lymphoma

Biology Behind Targeted Therapy for Lymphomas

Dr. Staudt talks about how ibrutinib is a very specific agent that has a high degree of efficacy with only modest side effects in treating the ABC form of Diffuse B-cell Lymphoma

  • Posted:
Email